Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aramis Biotechnologies

Request full access

Canadian biomanufcaturing company specializing in the production of innovative plant-based vaccines

Quebec City, CanadaFounded 2023Biotech & Life Sciences

About Aramis Biotechnologies

Aramis Biotechnologies, a Canadian company founded in 2023 and based in Quebec City, specializes in the development of a new generation of biomanufacturing platforms using plant-based technology. The company leverages the unique capabilities of plant cells to produce innovative vaccines and biotherapeutics.

The core of Aramis' technology is the use of plants as bioreactors, a method that supports the development of sustainable and effective solutions against various diseases. The company's primary focus is on advancing plant-based vaccines and therapeutics to combat influenza and other infectious diseases. This approach has led to significant breakthroughs in plant-based protein production, positioning the company as a notable player in the biotech space.

Aramis has established a partnership with the Biologics Manufacturing Centre, a collaboration that enhances its manufacturing and development capabilities. The company's structure is also noteworthy, with an employee-shareholder model that fosters a committed and driven team. Through its work, Aramis aims to provide innovative and sustainable health solutions to the global community.

Source: Dealroom company data

At a glance

Status
Operational
Employees
75
Open positions
None listed
Dealroom signal
77.1/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2024 $22M $88M Undisclosed ↗
DEBT✓Debt Dec 2024 $7.3M — Government of Quebec ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Aramis Biotechnologies website traffic

Latest recorded traffic for Aramis Biotechnologies is 1.5K monthly website visits, up 70.5% over the last three months. Aramis Biotechnologies's team grew 8.7% over the past year.

Latest monthly visits1.5K 3-month web change+70.5% 1-year team growth+8.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Aramis Biotechnologies in the Quebec City ecosystem

Live from Dealroom

The Aramis Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Government of Quebec

Other known investors1 additional known investor

  • Laval University
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇦 Canada98.6%
🇺🇸 United States1.4%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aramis Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aramis Biotechnologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.